Go offline with the Player FM app!
Seven Years Later: TAVR Didn't Blink 😎🫀
Manage episode 517706088 series 2740117
🫀 TAVR or SAVR? The 7-Year Truth
New 7-year results from the PARTNER-3 trial (NEJM) show that in low-risk patients with severe symptomatic aortic stenosis, TAVR holds pace with surgery — delivering comparable survival, stroke rates, rehospitalization, valve durability, and quality-of-life outcomes.
🔎 Highlights
• Composite events: 34.6% (TAVR) vs 37.2% (SAVR)
• Mortality: 19.5% vs 16.8%
• Valve failure: 6.9% vs 7.3%
• Aortic gradients remain low in both groups
💡 Clinical rhythm: less AF with TAVR; more pacemakers and paravalvular leak.
This study reinforces a simple truth: in the right low-risk patient, TAVR is not just less invasive — it's durable.
#Cardiology #StructuralHeart #AorticStenosis #TAVR #SAVR #NEJM
772 episodes
Manage episode 517706088 series 2740117
🫀 TAVR or SAVR? The 7-Year Truth
New 7-year results from the PARTNER-3 trial (NEJM) show that in low-risk patients with severe symptomatic aortic stenosis, TAVR holds pace with surgery — delivering comparable survival, stroke rates, rehospitalization, valve durability, and quality-of-life outcomes.
🔎 Highlights
• Composite events: 34.6% (TAVR) vs 37.2% (SAVR)
• Mortality: 19.5% vs 16.8%
• Valve failure: 6.9% vs 7.3%
• Aortic gradients remain low in both groups
💡 Clinical rhythm: less AF with TAVR; more pacemakers and paravalvular leak.
This study reinforces a simple truth: in the right low-risk patient, TAVR is not just less invasive — it's durable.
#Cardiology #StructuralHeart #AorticStenosis #TAVR #SAVR #NEJM
772 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.